sorry your right it was an unsolicited acquisition of the company. It begs the question why you wouldn't just do a T/O when the MC is this low.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling